Cenersen is under investigation in clinical trial NCT02243124 (A Study of Aezea® (Cenersen) in Transfusion Dependent Anemia Associated With Myelodysplastic Syndrome (MDS)).
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.